Beruflich Dokumente
Kultur Dokumente
Miss.RUCHI
Submitted to the Punjab Technical University In the partial fulfillment of the requirements For the degree of
ACKNOWLEDGEMENT
We feel proud privilege to extend our sincere thanks to all our well wishers who have affected our project work and us undoubtedly. We take credit for errors. We also take blame for the style which may at times appear to be reflection of our raw, undigested aimless empiricism.
Our foremost thanks to our Centre Head Mr. Bhupinderjeet Singh Bambah and Miss Ruchi (Project Incharge) and all other teachers of computer department who paved the way for us at every step in the progress of our project. We would also like to very sincerely thank our parents who supported us at every step. Without their guidance and support, this project would not have seen the light of the day .It is the place where we installed our first software and these people provided us that opportunity to remove the drawbacks of their existing system by software, which is very convenient for the examiners and students.
INTODUCTION
Inspired by a speech by antiseptic advocate Joseph Lister, Robert Wood Johnson, joined brothers James Wood Johnson and Edward Mead Johnson to create a line of ready-to-use surgical dressings in 1885. The company produced its first products in 1886 and incorporated in 1887. Robert Wood Johnson served as the first president of the company. He worked to improve sanitation practices in the
nineteenth century, and lent his name to a hospital in New Brunswick, New Jersey. Upon his death in 1910, he was succeeded in the presidency by his brother James Wood Johnson until 1932, and then by his son, Robert Wood Johnson II. Robert Wood Johnson's granddaughter, Mary Lea Johnson Richards, was the first baby to appear on a Johnson & Johnson baby powder label.[9][10][11] His great-grandson, Jamie Johnson, made a documentary called Born Rich about the experience of growing up as the heir to one of the world's greatest fortunes.
Corprate chairmanship
Company
Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world
Conducting business responsibly: Our Credo inspires us to do great things. We strive to deliver high-quality products andservices to meet our customers needs, and to do it accurately and promptly. We say we must treat each other with respect and be open to each others ideas. We promise to be good citizens of the world, protecting natural resources. We commit to experimenting with new ideas, and by extension, to learning from failure. By staying focused on these ideals, we will live up to our own expectations and those of our customers. Were listening to
our customers and other stakeholders to helpus to continue to be a trusted partner in health and well-being. For example, we held stakeholder dialogues on executive compensation and then redesigned our long-term incentive program for named executive officers with the aim of drawing more visible link between pay and performance. We became the first health care company to join the prestigious Billion Dollar Roundtable upon achieving global spending of at least $1 billion with diverse suppliers and increased our spend with diverse suppliers to $1.3 billion in 2011.
Challenges
Tightening integration of our quality systems across the enterprise. In 2011, McNeil Consumer Healthcare signed a consent decree with the U.S. Food and Drug Administration, which governs certain manufacturing operations. We incurred costs for the recall of DePuy Orthopaedics, Inc.s ASR XL Acetabular System and ASR Hip Resurfacing System. Reinforcing our culture of compliance. Stemming from subsidiaries outside the U.S. that were believed to have made improper payments in connection with the sale of medical devices, we entered into a three-year Deferred Prosecution Agreement with the U.S. Department of Justice and related
agreements with the U.S. Securities & Exchange Commission and the U.K. Serious Fraud Office. Reducing complexity and redundancies throughout our global supply chain so our companies can consistently produce high-quality products, maintain reliable supply and increase customer satisfaction. Manufacturing problems at a supplier created a shortage of Janssen Products, LPs cancer drug DOXIL (doxorubicin HCl liposome injection) in 2011.
Managing pricing pressures. Our Medical Devices and Diagnostics segment is facing more pressure on product prices because hospital customers are looking for cost relief. The global economy has also affected sales of medical devices, with people postponing non-acute care.
Reversing a 7 percent increase in crashes among our fleet of vehicles. While well below our baseline year of 1995, our crashes per million miles driven increased in 2011 to 5.94 from 5.53 in 2010. Continuing to reduce our water consumption. While we achieved a 1.2 percent absolute reduction in water in 2011, more than 15 years of implementing water-saving projects and the low cost of water make further water reduction projects less financially feasible.
Recent Products
Whether it's analgesics or baby care, endoscopic surgery or interventional cardiology, oral care or wound care, the Johnson & Johnson Family of Companies make products that help people live healthier lives. Below is a select list of some of our products introduced in the past 12 to 18 months.
Consumer Product
Our Consumer segment includes a broad range of products used in the baby care, skin care, oral care, wound care and womens health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. These products are marketed to the general public and sold to retail outlets and distributors throughout the world. The Consumer business relies on a research strategy equally rooted in technology and consumer insights, in keeping with our vision: BRINGING SCIENCE TO THE ART OF HEALTHY LIVINGTM Keeping Our Safety & Care Commitment is the most important thing we can do to continue earning your trust. Its why our assurance process is so rigorous. And its why were always listening to you so that we can improve our products and you can have complete peace of mind whenever you bring them into your home. To learn more, please go to our safety and care Commitment website to learn more.
health care professionals in the fields of orthopaedics, neurovascular surgery, vision care, diabetes care, infection prevention, diagnostics, cardiovascular disease, sports medicine, and aesthetics
Prescription Product
The Pharmaceutical segment of Johnson & Johnson invested $5.1 billion in 2011 on research & development. The Pharmaceutical segments broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience & pain, and oncology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use.
Management Approach
Johnson & Johnson is a company of enduring strength. We've been privileged to play a role in helping millions of people the world over be well and stay well through more than a century of change. As the science of human health and well-being has grown, we've been able to grow along with it. Even more important, we've helped shape and define what health and well-
being means in every day lives. Our products, services, ideas and giving now touch the lives of at least one billion people everyday.
We credit our strength and endurance to a consistent approach to managing our business, and to the character of our people. We are guided in everything we do by Our Credo, a management document authored more than 60 years ago by Robert Wood Johnson, former chairman from 1932 to 1963, and by four strategic principles.
Foundation The Strategic Framework starts with Our Credo, the guide to help us navigate our way through challenges and opportunities. From Our Credo, Our Aspiration emerges by caring, one person at a time, we help billions of people around the world live longer, healthier and happier lives. Strategic Principles We build from this foundation a unique set of strategic principles.
We are broadly based in health care. Our focus is on managing for the long term. We operate under a decentralized management approach. And we do all this through a unique culture that values and fosters the development of our people.
Growth Drivers
Our growth drivers are the specific areas of focus that help ensure our robust growth for the future. In today's highly competitive global marketplace, it is also essential that we focus on the critical drivers of our future growth: to create value through innovation, to extend our global reach, with local focus, to execute with excellence in everything we do. We pursue our growth drivers guided by the Leadership Imperatives: Connect, Shape, Lead and Deliver.
Credo Values
The values that guide our decision making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first. Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Companys founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term corporate social responsibility. Our Credo is more than
just a moral compass. We believe its a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
Johnson & Johnson Limited was ranked among the Top 50 best employers in India and # 2 among MNCs in the healthcare sector in the Survey conducted by the Great Places to Work Institute.
Johnson & Johnson Medical Indias DePuy Reach team won the Never Stop Moving award instrumental in touching lives of thousands of patients and in providing them with better standards of care. Johnson & Johnson Consumer India won the Media Abbys Gold for Youth Marketing for the Clean & ClearTM Fresh Face campaign.
Johnson & Johnson Consumer India won the Internationalists Award for innovation in Media for Lories for its Johnsons Baby.
Johnson & Johnson Consumer India won the Bangalore Ad Club Gold for the Stayfree Stories of Change campaign.
Johnson & Johnson Consumer India won the Bangalore Ad Club Silver in the OTC / Health Care section for the Nicorette Launch.
Johnson & Johnson Consumer's India Neutrogena enters Guinness World Record for the Largest Umbrella Mosaic with more
Micro Project
Designed to reach into the interiors of the country and are initiated by the Johnson & Johnson Location Committees. These projects call for a high degree of employee involvement and participation and help to spread Our Credo values organization-wide. Micro Projects span the following four pillars:
Saving & Improving Lives of Underprivileged Women and Children Building Healthcare Capacity Preventing Diseases, Reducing Stigma and Disability Community Responsibility
The keen interest and involvement of Johnson in a spectrum of Micro Projects has contributed towards a large number of underprivileged children gaining access to quality education and
With the help of Johnson & Johnsons India Contributions program, the Backward Class Girls Hostel, a Solapur-based NGO has introduced the Rugnasahayak (Patient Assistant) paramedical course of the Yashwantrao Chavan Maharashtra Open University. This course will equip the underprivileged girls residing in the hostel with the basic knowledge necessary to provide health and medical care in hospitals, nursing homes, old age homes etc. They will also be able to assist those in remote and rural areas with no access to medical care. Moreover, the underprivileged and unemployed girls enrolled in this course will have a means of livelihood and, therefore, economic freedom. The program has directly benefited 30 girls enrolled in the course. It will also benefit hospitals and nursing homes employing these girls, as well as the many patients who avail of their services Charudatta Aradhye of Johnson & Johnsons Mahim office has championed this project with unerring commitment and has ensured its success.
Johnson & Johnson has funded 50 underprivileged students enrolled in the Savitribai Phule Patient Assistant Course in partnership with Dr. Hedgewar Hospital. This course trains underprivileged girls as nurses, midwives, healthcare assistants etc, and encourages them to lead independent lives. It also enables underserved rural communities to access healthcare more easily. Johnson & Johnson arranged for an exposure visit for these girls to the companys Mumbai Branch in Mahim, where they were taken around the EISE training facility to observe cutting edge surgical equipment.
Adopt-a-School Program
Under the Adopt-a-School program, any Johnson & Johnson employee can identify a worthy school for the underprivileged and underserved in his/her vicinity. The program benefits underprivileged children by giving them access to education and garners employee participation in CSR activities. Under this program, funding is provided for basic facilities (class-room furniture, safe drinking water, hygienic toilet facilities, laboratory & library facilities etc.) that many of these schools lack.
Macro Projects
Macro Projects
Projects which have a wider geographical impact, at the State/National level. These projects have a long-term impact and are supported for 3-5 years.
Nanhi Kali
Johnson & Johnsons philanthropy has always focused on making a lifechanging, long-term impact on human society. One such project is the Nanhi Kali Project, which uses education as the primary tool for empowerment, to break the ongoing cycle of ignorance, socio-economic discrimination and vulnerability of girls and women, leading to abuse and exploitation.
The Nanhi Kali project aims to empower young girls with 10 years of quality formal education, towards helping them make appropriate choices regarding their health, family, life and future. Johnson & Johnsons funding will help educate over 1000 girl children from Madhya Pradesh and Andhra Pradesh. Johnson & Johnson has also been able to raise funds for t
Aarohi is a non-profit, organization promoting integrated rural development in the Central Himalayan region of Uttarakhand. Aarohis coverage spans 100 villages and has benefited approximately 37,000 people to date. Issues of poverty have been addressed through activities related to forest management, health care, livelihoods, drinking water and sanitation and womens development and education. Johnson & Johnson has funded the improvement of infrastructure in Aarohis primary school, its activities in the field of health and environment education, providing cultural and sports inputs to over 1500 children from 18 neighbouring villages
CASP is a national organization committed to the sustainable development of children, families and communities in backward districts, including urban slums. Currently CASP sponsors 12,208 children across India. In addition, community development programmes are undertaken relating to AIDS, sexual health, housing, adult education, family planning, a foster care scheme and more. A helping hand is also extended to families affected by natural disasters, as well as to children of people serving life imprisonment in Tihar Jail, Delhi. Johnson & Johnson sponsors 500 children in Tamhini, Maharashtra, which is under the aegis of the CASP Pune Unit.
Giving To
Johnson & Johnson and its many operating companies support community-based programs that improve health and well-being. Our community partners show us where our giving can help the most. We listen to them and we learn from them so that the programs we support make a meaningful difference in peoples lives. Together with our partners, we are helping mothers and infants survive childbirth. We are supporting doctors, nurses and local leaders as they work to provide the best medical care to their people. And we are educating communities on how to reduce their risk of infection from preventable diseases. The desire to make people healthier and safer is at the heart of our Companys giving.
Saving & Improving Lives We support programs for women and children who struggle to survive in places with limited health care, education or social support.
Building Health Care Capacity We partner with respected groups to build the skills of people who serve community health needs, primarily through education.
Preventing Diseases We work with communities to prevent chronic disease like HIV/AIDS and diabetes, and help people cope with the stigmas of disease and mental illness.
Every day, scientists and doctors discover new information about health and disease and how various products are best used on behalf of patients. Medical specialty societies, academic institutions and other groups that provide medical education often look to pharmaceutical and medical device companies to support their education programs.We believe this is an important way to advance medicine and health care, and our companies are expected to follow a set process when making educational grants. The guiding principles we use to evaluate whether to support such programs are based on recognized standards:
Dedication to Quality
Training programs at Johnson & Johnson companies give employees the necessary tools to create and manage quality systems that ensure our products perform the way they are supposed to and meet all regulatory requirements Many of our businesses and facilities have been certified to meet International Organization for Standardization (ISO) requirements for quality management. ISO certification means that aquality management system has been thoroughly reviewed by an outside audit committee and found to satisfy rigorous standards when it comes to such important principles as customer focus, leadership, employee involvement, and continual improvement. All Johnson & Johnson operating company facilities that make medicines or medical devices meet current Good Manufacturing Practices (cGMP) outlined by the FDA or one or more other national regulatory agencies. Our companies work closely with health authorities, various standard-setting bodies, and professional organizations worldwide to be sure our quality systems are up-todate and continually improving.
Cost-Sharing
Cost sharing, or requiring a person to pay a portion of his health care services, is commonly used to discourage patients from seeking unnecessary medical care. Cost sharing often takes the form of a co-payment or co-pay, which is usually only a small fraction of the actual cost of the medical service. The remainder of the cost is covered by the persons insurance company or by the government payer. Some research suggests that, at times, copays may serve to discourage some people from
using certain types of care. A RAND study found that people with chronic diseases who were receiving routine care cut their use of needed prescription medicines when they had co-pays.On the other hand, financial incentives such as no co-pays for high-risk patients may help to improve how well patients follow their prescribed treatment.
Taking Action
At Johnson & Johnson, we advocate for policies that appropriately use incentives to improve care, and we work to alleviate disincentives for patients who cannot afford to pay for their prescription medications. Weve also developed our own health incentives for employees. This includes a comprehensive Healthy People program based on the U.S. governments Healthy People 2010 initiative. Through this program, we provide incentives to our employees and their families that encourage them to adopt preventative lifestyles and make healthy choices.
At Johnson & Johnson, we believe that effective, compassionate health care systems are critical to achieving better health for people around the world. Such systems are centered on the needs of individuals, offer access to health care coverage for all, and provide people with information, encouragement, incentives and support to remain healthy, to obtain early diagnoses and to receive quality care and treatment when it is needed. We believe that people everywhere are served best when health care systems: Focus attention on prevention and public health measures in addition to acute and chronic care Address the need for access to care across all economic and social circumstances;
Allow patients and their health care practitioners to choose the best course of treatment; Support health choices with scientifically sound clinical and economic evidence; Protect the privacy of everyones personal medical records; Provide for both public and private health care funding solutions; Provide incentives for medical progress; Promote market-based competition; Are characterized by strong and well-respected regulatory authorities; Promote transparent and ethical interactions among stakeholders; Are adequately funded to support the health care needs of individuals; Allow individuals, health care professionals, caregivers and payers to have access to up-to-date health information to help guide decisions; Operate efficiently, providing affordable, quality, timely and continuous care, and maximum, equitable access.
Role
We believe that, as a member of the global health care community, Johnson & Johnson has a responsibility to advance good health care through our actions as well as to work with others to help shape effective health care systems around the world that will serve the needs of people. We recognize that all members of the health care community must collaborate to achieve this goal. Using the vantage point of our broad base in health care, we will Work to address unmet medical needs through science and innovation, using our talents and commitment to improve health care; Support efforts to enhance access to health care and health care products; Provide appropriate clinical and economic information about our products and treatments, as well as broad health, disease and prevention information, to individuals, health care practitioners, caregivers and payers in ways that facilitate health care decision-making;
Values-based leadership.
Our Credo outlines the values that provide the foundation of how we act as a corporation and as individual employees so that we continue to put the needs of the people we serve first.
Diversity.
Its our individual differences that make us stronger as a whole. We recognize the strength and value that comes when collaborative relationships are built between people of different ages, race, gender, religion, nationality, sexual orientation,
physical ability, thinking style, personal backgrounds and all other attributes that make each person unique.
Innovation.
True innovation can only be fostered within a supportive environment that values calculated risk in order to achieve the maximum reward. At Johnson & Johnson Inc., we encourage and reward innovative thinking, innovative solutions and an innovative approach in all that we do.
Passion.
The deep desire to enrich peoples lives by delivering quality products and remarkable experiences that make their lives easier, healthier and more joyful.
Collaboration.
The unwavering belief that great results depend on the ability to create trusting relationships.
Courage.
The fearless pursuit of the unproven, unknown possibility the willingness to take great risks for the benefit of the greater good.
"We are responsible to the communities in which we live and work and to the world community as well. We must be good citizens support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources." Our Credo
employees. Its no wonder we are known as a trusting and caring company around the world.
Community Giving
Through our innovative programs, sponsorships and product donations, we focus on making a difference in the communities in which we live and work.
Environmental Commitment
Since our companys beginning, weve placed a high priority on keeping our earth healthy.
For Johnson & Johnson Inc. employees there are a broad range of career development opportunities within our organization or with other members of the Johnson & Johnson Family of Companies in Canada or around the world. To support the most effective career development process for our employees, we provide coaching, mentoring, comprehensive feedback, career development planning and a highly personalized dialogue between you and your manager.
Our Performance Development Planning Process is a dynamic and continuous one that helps ensure the successful career development of our employees as much as it does our business objectives:
At mid-year Employees and managers engage in discussions to assess performance-relative career goals and objectives and to determine if changes are required or if additional support is needed.
A formal written performance evaluation takes place where new or adjusted career goals and career development opportunities are identified for the following year, and a personal career development plan is discussed and
documented.
Johnson & Johnson (NYS: JNJ) reported earnings on Jan. 22. Here are the numbers you need to know.
Revenue details Johnson & Johnson notched revenue of $17.56 billion. The 17 analysts polled by S&P Capital IQ foresaw a top line of $17.67 billion on the same basis. GAAP reported sales were 8.0% higher than the prior-year quarter's $16.26 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $1.19. The 21 earnings estimates compiled by S&P Capital IQ predicted $1.16 per share. GAAP EPS of $0.91 for Q4 were much higher than the prior-year quarter's $0.08 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates. Margin details For the quarter, gross margin was 65.8%, 140 basis points worse than the prior-year quarter. Operating margin was 20.3%, about the same as the prior-year quarter. Net margin was 14.6%, 1,330 basis points better than the prior-year quarter.
Looking ahead Next quarter's average estimate for revenue is $17.63 billion. On the bottom line, the average EPS estimate is $1.40. Next year's average estimate for revenue is $72.20 billion. The average EPS estimate is $5.50. Investor sentiment The stock has a five-star rating (out of five) at Motley Fool CAPS, with 13,550 members out of 14,043 rating the stock outperform, and 493 members rating it underperform. Among 3,288 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 3,220 give Johnson & Johnson a green thumbs-up, and 68 give it a red thumbs-down. Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Johnson & Johnson is outperform, with an average price target of $75.42. Can your portfolio provide you with enough income to last through retirement? You'll need more than Johnson & Johnson. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.